Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksMEDANTA
resources
MEDANTA

Global Health Ltd.

NSE: MEDANTA
BSE: 543654
Sector: Healthcare
Industry Group: Healthcare Services
Industry: Hospital
1,409.70+1.5 (+0.11%)
21 Aug, 12:00 AM

Annual Reports and Financial Documents

Global Health Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Global Health Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Analyst / Investor Meet22 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
  2. Analyst / Investor Meet22 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Announcement under SEBI Listing Regulations regarding Schedule of Institutional Investor Meet.
  3. Newspaper Publication22 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Post Dispatch Advertisement for the 22nd Annual General Meeting for the Financial Year 2025-26.
  4. General21 Aug 2026
    Letter To Shareholders Providing The Weblink Of Annual Report For The FY 2025-26
    Enclosed.
  5. Business Responsibility and Sustainability Reporting (BRSR)21 Aug 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    Business Responsibility and Sustainability Report along with Assurance Report for the Financial Year 2025-26.
  6. Reg. 34 (1) Annual Report21 Aug 2026
    Reg. 34 (1) Annual Report.
    Please find enclosed herewith the Annual Report along with BRSR and AGM Notice for Financial Year 2025-26.
  7. AGM21 Aug 2026
    Notice Of 22Nd Annual General Meeting Scheduled To Be Held On Wednesday, September 16, 2026 Through Video Conferencing (VC)/ OAVM For The Financial Year 2025-26.
    Enclosed
  8. Analyst / Investor Meet18 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Announcement under SEBI Listing Regulations regarding Schedule of Analyst Meet.
  9. Newspaper Publication12 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copy of Pre-advertisement of Annual General Meeting 2026.
  10. Analyst / Investor Meet31 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Intimation under Regulation 30 of SEBI Listing Regulations 2015- Audio Recording.
  11. Newspaper Publication31 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper publication under Regulation 30 and 47 of SEBI Listing Regulations.
  12. Date of payment of Dividend31 Jul 2026
    Announcement under Regulation 30 (LODR)-Date of payment of Dividend
    Intimation under Regulation 30 of Listing Regulations regarding Dividend.
  13. Press Release / Media Release30 Jul 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release for the First Quarter ended June 30, 2026, Results
  14. Meeting Updates30 Jul 2026
    Announcement under Regulation 30 (LODR)-Meeting Updates
    Board Meeting Intimation under Regulation 30 of Listing Regulations regarding the Capacity Addition.
  15. Record Date30 Jul 2026
    Fixation Of Records Date For Declaration Of Dividend.
    It is informed that Company has fixed August 14, 2026, as Record Date for the declaration of Dividend.
  16. Change in Management30 Jul 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Announcement regarding appointment of Mr. Pradeep Kumar Singh as one of the Senior Management Personnel.
  17. Outcome of Board Meeting30 Jul 2026
    Board Meeting Outcome for Board Meeting Outcome For Intimation Under Regulation 30 Of SEBI Listing Regulations.
    Outcome of Board Meeting held today i.e. July 30, 2026, to consider Unaudited Financial Results for Quarter ended June 30, 2026.
  18. Meeting Updates30 Jul 2026
    Announcement under Regulation 30 (LODR)-Meeting Updates
    It is informed that the Nomination & Remuneration Committee in its Meeting held on July 30, 2026, has made a grant of 20,000 ESOPs under GHL LTIP 2024
  19. Analyst / Investor Meet24 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation for Earning Conference Call under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.
  20. Board Meeting20 Jul 2026
    Board Meeting Intimation for Schedule Of Board Meeting For The First Quarter Ended June 30, 2026, Under Regulation 29 Of Listing Regulations.
    Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve Unaudited Financial Results for ....

Frequently Asked Questions

Where can I download the annual report of Global Health Ltd.?
Annual reports of Global Health Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Global Health Ltd.?
Quarterly earnings results and presentations of Global Health Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Global Health Ltd. publish earnings call transcripts?
Earnings call transcripts of Global Health Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Global Health Ltd.?
Investor presentations and annual day presentations of Global Health Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Global Health Ltd.?
Corporate announcements and regulatory filings of Global Health Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Global Health Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Global Health Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Global Health Ltd.?
The ISIN (International Securities Identification Number) of Global Health Ltd. is INE474Q01031. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Global Health Ltd. listed?
Global Health Ltd. is listed on NSE and BSE. The NSE symbol is MEDANTA and the BSE code is -.
Where can I find the shareholding pattern of Global Health Ltd.?
The quarterly shareholding pattern of Global Health Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Global Health Ltd. on Sharpely?
Share price data for Global Health Ltd. is updated as of 21 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.